← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #542 OF 1,000 MOST-CITED

Verification - CCP, CA record review

FDA cited this observation 34 times across 30 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods34
BY FISCAL YEAR
FY20261
FY20251
FY20241
FY20226
FY20204
FY201914
FY20185
FY20172

How FDA worded it — real examples

You did not review all of your critical control point monitoring records within one week (7 days) of the day the records are made.

Select Juice, LLC · Lancaster, Pennsylvania · Foods · 2026-06-03

You did not review all of your critical control point monitoring records within one week (7 days) of the day the records are made.

AME Foods, Inc. · Anaheim, California · Foods · 2025-07-21

You did not review your critical control point monitoring records within one week (7 days) of the day the records are made.

CC1 Limited Partnership dba Coca-Cola Puerto Rico Bottlers · Cayey, Puerto Rico · Foods · 2024-09-30

You did not review all of your critical control point monitoring records within one week (7 days) of the day the records are made.

MacQueen Orchards Inc · Holland, Ohio · Foods · 2022-09-30

You did not review all of your critical control point monitoring records within one week (7 days) of the day the records are made.

Supreme Manufacturing Co, Inc. · East Brunswick, New Jersey · Foods · 2022-09-30

You did not review all of your critical control point monitoring records within one week (7 days) of the day the records are made.

AME Foods, Inc. · Anaheim, California · Foods · 2022-08-08

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →